Abstract

P016 The Optimal ALK inhibitor in Advanced ALK-Positive NSCLC Patients: An Indirect Comparison Between Brigatinib and Alectinib

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer
Ha Yeon Lee ... Jin Seok Ahn
Lung cancer (Amsterdam, Netherlands) | VOL. 79
Ha Yeon Lee, et. al.Ha Yeon Lee ... Jin Seok Ahn
25 Oct 2012
Abstract 579: Ensartinib (X-396), a novel ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation and expansion study
Hongyun Zhao ... Yuxiang Ma
American Journal of Cancer | VOL. 80
Hongyun Zhao, et. al.Hongyun Zhao ... Yuxiang Ma
13 Aug 2020
The role of brigatinib in crizotinib-resistant non-small cell lung cancer.
Laura Mezquita ... David Planchard
Cancer Management and Research | VOL. 10
Laura Mezquita, et. al.Laura Mezquita ... David Planchard
01 Jan 2018
Anaplastic Lymphoma Kinase (Alk) Positivity in Non Small Cell Lung Cancer (Nsclc) Has Similar or Worse Prognosis for Clinical Outcome As Alk Wild Type: a Systematic Review of Published Literature
J Binko ... P Delahoy
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 25
J Binko, et. al.J Binko ... P Delahoy
01 Sep 2014
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.95 STK11, KEAP1, and KRAS mutation epidemiology and real-world outcomes in US patients with newly diagnosed metastatic non-small cell lung cancer
Firas Dabbous ... Ferdinandos Skoulidis
Journal of Thoracic Oncology | VOL. 19
Firas Dabbous, et. al.Firas Dabbous ... Ferdinandos Skoulidis
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
View more papers